Verrica Pharmaceuticals Inc.
Verrica Pharmaceuticals Inc. scores highest on Anchor (49) and lowest on Price (5). Its PosiPenta is 30.34 out of 100, weaker than most similar companies.
On the Penta Grid this week, Verrica Pharmaceuticals Inc. is Grid #755 of 837 in the Healthcare sector in United States, and Grid #3,596 of 4,000 in United States.
Compared with similar companies in the Healthcare sector in United States.
The five pillars
Similar companies
| Company | PosiPenta | P | E | N | T | A |
|---|---|---|---|---|---|---|
| Verrica Pharmaceuticals Inc. | 30.34 | 5 | 34 | 31 | 33 | 49 |
| Spero Therapeutics, Inc. | 51.82 | 75 | 39 | 24 | 74 | 47 |
| Tenax Therapeutics, Inc. | 37.13 | 46 | 31 | 8 | 65 | 34 |
| Oncolytics Biotech Inc. | 44.43 | 0 | 59 | 33 | 93 | 37 |
| Champions Oncology, Inc. | 44.85 | 4 | 83 | 40 | 35 | 62 |
| Fortress Biotech, Inc. | 57.23 | 93 | 46 | 27 | 69 | 50 |
Similar-sized companies in the same sector, this week. P Price · E Earnings · N Nitro · T Torque · A Anchor.
Details
PPrice
| P/E ratio | -2.05 |
| P/B ratio | 14.34 |
EEarnings
| Trailing EPS | ₹-165.75 |
| Forward EPS | ₹-139.94 |
NNitro
| Price | 340.50 |
| 52-week high | 930.20 |
| 52-week low | 310.67 |
| Fall from 52-week high | 63.4% |
TTorque
| Return on equity (ROE) | — |
| Debt-to-equity | 0.42 |
AAnchor
| Beta (price swings) | 1.61 |
| Market cap | ₹584 Cr |
| Insider holding | 49.00% |
| Dividend yield | 0.00% |
Figures as used for the week of 17 Oct 2026; today's figures on the company page may differ slightly.
Questions
What is Verrica Pharmaceuticals Inc.'s PosiPenta score?
Verrica Pharmaceuticals Inc.'s PosiPenta is 30.34 out of 100 for the week of 17 Oct 2026, based on 5 of 5 pillars.
Where does Verrica Pharmaceuticals Inc. stand on the Penta Grid?
On the Penta Grid this week, Verrica Pharmaceuticals Inc. is Grid #755 of 837 in the Healthcare sector in United States, and Grid #3,596 of 4,000 in United States.
Which PosiPenta pillar is strongest for Verrica Pharmaceuticals Inc.?
Anchor (stability and dividends), with a score of 49 out of 100: around the middle of similar companies.
Which PosiPenta pillar is weakest for Verrica Pharmaceuticals Inc.?
Price (valuation), with a score of 5 out of 100: much weaker than most similar companies.
Has Verrica Pharmaceuticals Inc.'s PosiPenta changed since last week?
Yes, it rose 1.83 points, from 28.51 to 30.34.
PositoAI is for research and education only and is not investment advice.